PathAI enters into clinical diagnostics through acquisition of Poplar Healthcare Management


PathAI, a global provider of artificial intelligence-powered technology for pathology, announced their acquisition of Poplar, the management service organization for Poplar Healthcare PLLC, an industry-leading independent anatomic pathology laboratory services provider. “Our mission at PathAI is to improve patient outcomes with AI-powered pathology and the investment in Poplar allows us to advance that mission by enhancing our ability to provide pathologists with PathAI diagnostic products to support patient care.” said Andy Beck MD, PhD, co-founder and CEO of PathAI. “Poplar is a top tier lab with a dedicated team known for their accuracy of diagnosis and turnaround time. PathAI’s investments in digital pathology and artificial intelligence will further enhance Poplar’s value proposition to providers across the United States.”

Read More

Next Post

International Conference on Medical & Health Science

International Conference on Medical and Health Science aim of the conference is to provide the platform for Students, Doctors, Researchers and Academicians to share the knowledge and ideas in the recent trends in the field of Medical and Health Science. 04 – 05 Aug 2021, Frankfurt, Germany Read More